47
Participants
Start Date
December 6, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
BI 3706674
BI 3706674
National Taiwan University Hospital, Taipei
NCKUH, Tainan City
Memorial Sloan-Kettering Cancer Center, New York
Seoul National University Bundang Hospital, Seongnam
Ajou University Hospital, Suwon
University of Pennsylvania, Philadelphia
The University of Texas MD Anderson Cancer Center, Houston
Mayo Clinic-Arizona, Phoenix
Yale Cancer Center, New Haven
Massachusetts General Hospital, Boston
National Cancer Center Hospital East, Chiba, Kashiwa
Japanese Foundation for Cancer Research, Tokyo, Koto-ku
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
The Catholic University of Korea, Seoul St.Mary's Hospital, Seoul
Lead Sponsor
Boehringer Ingelheim
INDUSTRY